register

News & Trends - Pharmaceuticals

PBS process improvements impacted by COVID-19

Health Industry Hub | April 29, 2020 |

Pharma News: On 12 February 2020, the Department of Health hosted a webinar to commence broad consultation on proposed fee changes for Pharmaceutical Benefits Scheme (PBS) and National Immunisation Plan (NIP) listings.

This was followed by a public consultation period from 17 February to 16 March 2020.

As outlined at the webinar and in the consultation document, Stage 2 PBS process improvements and supporting cost recovery arrangements were to be implemented from 1 July 2020, pending Government agreement.

Overview of Stage 2 PBS Process Improvements

  1. Changes to initial submission categories (including introduction of a single submission date)
  2. Introduction of resubmission pathways for submissions not recommended by the PBAC
  3. Revised cost recovery arrangements to support implementation of Stage 2 process improvements.
  4. Other improvements, including IT system changes

You may also like PRIME Awards 2020 call for entries – the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.

The current COVID-19 pandemic may impact the government approval of Stage 2 PBS process improvements and supporting cost recovery arrangements and a 1 July 2020 implementation date is now unlikely.

As a result, applicants should be prepared for the current processes and the 2020-21 fees indicated in the 2019-20 Cost Recovery Implementation Statement (CRIS) and the Regulations, pending government approval of some minor amendments, to commence from 1 July 2020.  These proposed 2020-21 fees were included in consultations last year.

A 2020-21 CRIS, which will outline the fees to apply from 1 July 2020 will be released as soon as possible.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.


Human Resources

Decoding Novartis' blueprint for AI-powered workforce and a reimagined workplace: International HR Day 2025

Decoding Novartis’ blueprint for AI-powered workforce and a reimagined workplace: International HR Day

Health Industry Hub | May 16, 2025 |

As International HR Day (20 May) spotlights the theme HumanifyAI – Leading Change in a Dynamic World, Saada McNamee, Country […]

More


Medical and Science

What powers GenesisCare’s bold path in cancer research: Clinical Trials Day

What powers GenesisCare’s bold path in cancer research: Clinical Trials Day

Health Industry Hub | May 16, 2025 |

What does it take to deliver research that truly changes lives? For Sonya McColl, National Research Manager of Oncology at […]

More


News & Trends - MedTech & Diagnostics

Are we chasing value-based healthcare while ignoring the elephant in the hospital corridor?

Are we chasing value-based healthcare while ignoring the elephant in the hospital corridors?

Health Industry Hub | May 16, 2025 |

The health system is stuck in a volume-driven framework that rewards throughput over quality. It’s a model that no longer […]

More


News & Trends - MedTech & Diagnostics

Former APHA CEO joins day hospitals group amid strategic growth phase

Former APHA CEO joins day hospitals group amid strategic growth phase

Health Industry Hub | May 16, 2025 |

Cura Day Hospitals Group has announced the appointment of Michael Roff, former CEO of the Australian Private Hospitals Association (APHA), […]

More


This content is copyright protected. Please subscribe to gain access.